Skip to main content
Premium Trial:

Request an Annual Quote

Aventis Extends Spotfire Deal

NEW YORK, June 19-Aventis has signed a new multi-year deal with Spotfire for expanded use of the database querying and analysis program DecisionSite, the software company said today.


Under the terms of this deal, the two will work jointly to adapt Spotfire software for Aventis' drug discovery efforts. The pharmaceutical company also has access to a new module of the software.


The deal extends an agreement made last June, whereby Spotfire and IBM are collaborating to combine their information management, infrastructure and biological analysis capabilities for the benefit of Aventis.The pharmaceutical giant is using Spotfire and IBM products for all its research and discovery efforts.


For more information, click here.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.